FDA Inspection 1142118 — HWI Pharma Services GmbH
The FDA completed an inspection of HWI Pharma Services GmbH on Sep 26, 2019 in Rulzheim. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 26, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rulzheim (Germany)
Additional Details
Mutual Recognition Agreement (MRA)